Dr. Murphy on Glioma Prognostic Factors in Younger Patients

Erin Murphy, MD
Published: Wednesday, Jan 06, 2016



Erin Murphy, MD, associate staff, Department of Radiation Oncology, Cleveland Clinic, discusses a study examining prognostic factors of patients with glioma.

The study included a database of more than 600 patients with low-grade glioma who were aged 40 and younger to determine the importance of their molecular features.

Data showed that classic prognostic factors, such as extent of resection, histology, and presentation of seizures and tumor size, still have an impact on prognosis. However, 1p/19q status was not found to have a significant impact on progression-free or overall survival, Murphy explains.



Erin Murphy, MD, associate staff, Department of Radiation Oncology, Cleveland Clinic, discusses a study examining prognostic factors of patients with glioma.

The study included a database of more than 600 patients with low-grade glioma who were aged 40 and younger to determine the importance of their molecular features.

Data showed that classic prognostic factors, such as extent of resection, histology, and presentation of seizures and tumor size, still have an impact on prognosis. However, 1p/19q status was not found to have a significant impact on progression-free or overall survival, Murphy explains.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x